Certara sells biosimulation software, regulatory writing tools, and consulting services that help drug developers and regulators make decisions. It last closed at $11.06 on Nov 17, down 2.90% on the day. The average 12-month price target from 3 analysts is $11.00 (-0.5% from the last close), with a high of $12.00 and a low of $10.00. Analyst consensus is Hold, based on the latest ratings from 3 firms (1 buy, 2 hold, 0 sell).
Each firm's latest rating on CERT in the past 90 days
Average 12-month target
$11.00
▼ 0.5% downside
Based on 3 analysts who set a price target on CERT in the past 90 days. The average target is $11.00, with a high of $12.00 and a low of $10.00, compared with the last close of $11.06.
Low $10.00Avg $11.00High $12.00
Blue marker: last close $11.06
Highest target$12.00
Average target$11.00
Lowest target$10.00
Latest rating changes
BarclaysTarget raised
Nov 6Hold$9 → $12
TD CowenMaintained
Oct 13Buy$11
BarclaysTarget raised
Oct 7Hold$7.50 → $9
UBSDowngrade
Sep 30Hold$10
BarclaysMaintained
Aug 5Hold$7.50
Date
Firm
Action
Rating
Price target
Nov 6
Barclays
Target raised
Hold
$9 → $12
Oct 13
TD Cowen
Maintained
Buy
$11
Oct 7
Barclays
Target raised
Hold
$7.50 → $9
Sep 30
UBS
Downgrade
Hold
$10
Aug 5
Barclays
Maintained
Hold
$7.50
Loading…
Technical Analysis
CERT · as of the Nov 17 close · updated after every close
Uptrend
The stock sits between its 20 and 50 day averages. It is 33% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 53). The nearest support is the Pivot S1 at $10.89, and the nearest resistance the Pivot at $11.22.
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 5.2%/day
Key levels
$12.6152 week high+14.0%
$11.73Swing high (Oct 28)+6.1%
$11.39Pivot R1+3.0%
$11.2420 day average+1.6%
$11.22Pivot+1.4%
$11.06Last close
$10.89Pivot S1−1.5%
$10.46Swing low (Nov 3)−5.4%
$9.8350 day average−11.1%
$8.74100 day average−21.0%
$7.39200 day average−33.2%
$4.4552 week low−59.8%
Indicators
RSI (14)
52.54
Middle of its range
Neutral
MACD
0.52
Below its signal line
Bearish
Stochastic
41.1
Middle of its range
Neutral
ADX (14)
47.7
Strong uptrend
Williams %R
-72.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
2.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.8%
Change over 10 sessions
Bullish
ATR (14)
$0.58
Typical daily range, 5.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNear overbought
VolatilityNormal, 9.4%/day
Key levels
$12.6152 week high+14.0%
$11.73Swing high (Oct 28)+6.1%
$11.39Pivot R1+3.0%
$11.2420 day average+1.6%
$11.22Pivot+1.4%
$11.06Last close
$10.89Pivot S1−1.5%
$10.46Swing low (Nov 3)−5.4%
$9.8350 day average−11.1%
$8.74100 day average−21.0%
$7.39200 day average−33.2%
$4.4552 week low−59.8%
Indicators
RSI (14)
66.01
Strong, overbought above 70
Neutral
MACD
1.09
Above its signal line
Bullish
Stochastic
80.7
Near the top of its range
Overbought
ADX (14)
28.6
Trending up
Williams %R
-29.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
123.5
Oversold below −100, overbought above 100
Overbought
Rate of change
+46.5%
Change over 10 sessions
Bullish
ATR (14)
$1.04
Typical daily range, 9.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for CERT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CERT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow CERT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CERT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CERT is in one of them and how their past CERT trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Certara
Certara is based in Radnor, Pennsylvania, and provides biosimulation software, regulatory science tools, and consulting services for drug development. Its products include the Simcyp Simulator, which predicts how drugs behave in the body, and the Phoenix software for analyzing pharmacokinetic data. The company also offers CoAuthor software and related services to help draft regulatory submissions. Its customers include biopharmaceutical and biotech companies, academic institutions, and drug regulatory agencies.